Cardiogen

Cardiogen is a synthetic tetrapeptide (Ala-Glu-Asp-Arg) from the Khavinson class of bioregulatory peptides developed at the Saint Petersburg Institute of Bioregulation and Gerontology. It is designed to target cardiac (myocardial) tissue through proposed peptide-DNA interactions that modulate gene expression in cardiomyocytes. The Khavinson bioregulatory model proposes that short peptide sequences (2-4 amino acids) can interact with specific regions of DNA in a tissue-selective manner, influencing transcription of genes involved in tissue maintenance and cellular homeostasis. Cardiogen has been investigated in Russian biogerontology research for its potential effects on cardiac tissue biology, including studies examining cardiomyocyte differentiation markers, extracellular matrix composition, and age-related changes in cardiac gene expression. It is one of several organ-specific tetrapeptides in the Khavinson bioregulator family.

Cardiogen has been investigated for its proposed interactions with gene regulatory regions in cardiac cells, consistent with the Khavinson bioregulatory peptide model. Researchers in this field propose that the Ala-Glu-Asp-Arg sequence penetrates cell membranes and interacts with specific DNA sequences in promoter regions of cardiac-expressed genes. In preclinical cell culture models, researchers observed that Cardiogen treatment was associated with changes in expression of cardiac differentiation markers and structural proteins including cardiac troponins and connexin-43. Studies from the Saint Petersburg group suggest that Cardiogen may influence cardiomyocyte proliferation and survival markers in culture systems. The peptide has also been investigated for its effects on cardiac tissue in aging models, where researchers observed changes in collagen-to-elastin ratios and matrix metalloproteinase expression. These effects are attributed to the peptide’s proposed epigenetic regulatory activity rather than conventional receptor signaling.

Cardiac Gene Expression

Khavinson et al. (2003) investigated Cardiogen in cardiac tissue culture models and observed changes in expression of differentiation markers in cardiomyocytes. The study proposed that the tetrapeptide interacts with promoter regions of cardiac-specific genes [1].

Bioregulatory Peptides and Aging

Khavinson VK (2002) described the broader framework of bioregulatory peptides including Cardiogen, presenting data from preclinical studies on tissue-specific peptides across multiple organ systems including the heart [2].

Short Peptide-DNA Interactions

Fedoreyeva et al. (2011) investigated the binding of short peptides to DNA using fluorescence spectroscopy. Researchers demonstrated that tetrapeptides including those with similar charge distributions to Cardiogen could interact with specific DNA sequences in vitro [3].